These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia. Hu X; Dallinga-Thie GM; Hovingh GK; Chang SY; Sandoval NP; Dang TLP; Fukamachi I; Miyashita K; Nakajima K; Murakami M; Fong LG; Ploug M; Young SG; Beigneux AP J Clin Lipidol; 2017; 11(4):964-971. PubMed ID: 28666713 [TBL] [Abstract][Full Text] [Related]
3. Marked hypertriglyceridemia with a novel splicing mutation in GPIHBP1. Kawahara S; Imagawa K; Suzuki H; Ohto T; Takada H Pediatr Int; 2023; 65(1):e15559. PubMed ID: 37350556 [No Abstract] [Full Text] [Related]
4. An ELISA for quantifying GPIHBP1 autoantibodies and making a diagnosis of the GPIHBP1 autoantibody syndrome. Miyashita K; Fukamachi I; Machida T; Nakajima K; Young SG; Murakami M; Beigneux AP; Nakajima K Clin Chim Acta; 2018 Dec; 487():174-178. PubMed ID: 30287259 [TBL] [Abstract][Full Text] [Related]
5. Triglyceride Metabolism under Attack. Kersten S Cell Metab; 2017 Jun; 25(6):1209-1210. PubMed ID: 28591627 [TBL] [Abstract][Full Text] [Related]
6. Development of hypertriglyceridemia due to GPIHBP1 autoantibodies prior to clinical diagnosis of systemic lupus erythematosus in a 14-year-old girl. Kunitsu T; Harada-Shiba M; Sato T; Nonomura K; Kimura T; Miyashita K; Nakajima K; Murakami M Allergol Int; 2022 Oct; 71(4):555-557. PubMed ID: 35662538 [No Abstract] [Full Text] [Related]
7. Novel combined GPIHBP1 mutations in a patient with hypertriglyceridemia associated with CAD. Yamamoto H; Onishi M; Miyamoto N; Oki R; Ueda H; Ishigami M; Hiraoka H; Matsuzawa Y; Kihara S J Atheroscler Thromb; 2013; 20(10):777-84. PubMed ID: 23831619 [TBL] [Abstract][Full Text] [Related]
8. GPIHBP1 and Plasma Triglyceride Metabolism. Fong LG; Young SG; Beigneux AP; Bensadoun A; Oberer M; Jiang H; Ploug M Trends Endocrinol Metab; 2016 Jul; 27(7):455-469. PubMed ID: 27185325 [TBL] [Abstract][Full Text] [Related]
9. Abnormality of hepatic triglyceride metabolism in Apc Yu B; Zhang M; Chen J; Wang L; Peng X; Zhang X; Wang H; Wang A; Zhao D; Pang D; OuYang H; Tang X Life Sci; 2019 Jun; 227():201-211. PubMed ID: 31002917 [TBL] [Abstract][Full Text] [Related]
10. Quantification and genotyping of lipoprotein lipase in patients with diabetic lipaemia. Radhakutty A; Shen J; Hooper AJ; Miller SA; Burnett JR; Mah PM; Burt MG; Doogue MP Diabet Med; 2014 Dec; 31(12):1702-7. PubMed ID: 25131724 [TBL] [Abstract][Full Text] [Related]
11. Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis. Ariza MJ; Martínez-Hernández PL; Ibarretxe D; Rabacchi C; Rioja J; Grande-Aragón C; Plana N; Tarugi P; Olivecrona G; Calandra S; Valdivielso P J Clin Lipidol; 2016; 10(1):92-100.e1. PubMed ID: 26892125 [TBL] [Abstract][Full Text] [Related]
12. Building bridges: PCSK7 as a NAFLD candidate gene connecting hepatic inflammation with hypertriglyceridemia. Carr RM; Davidson NO J Lipid Res; 2019 Jun; 60(6):1067-1068. PubMed ID: 31023721 [No Abstract] [Full Text] [Related]
13. A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene. Buonuomo PS; Bartuli A; Rabacchi C; Bertolini S; Calandra S J Clin Lipidol; 2015; 9(2):265-70. PubMed ID: 25911085 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein lipase transporter GPIHBP1 and triglyceride-rich lipoprotein metabolism. Liu C; Li L; Guo D; Lv Y; Zheng X; Mo Z; Xie W Clin Chim Acta; 2018 Dec; 487():33-40. PubMed ID: 30218660 [TBL] [Abstract][Full Text] [Related]
15. Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance. Surendran RP; Udayyapan SD; Clemente-Postigo M; Havik SR; Schimmel AWM; Tinahones F; Nieuwdorp M; Dallinga-Thie GM PLoS One; 2018; 13(11):e0205858. PubMed ID: 30408040 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs. Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108 [TBL] [Abstract][Full Text] [Related]
17. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding. Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803 [TBL] [Abstract][Full Text] [Related]
18. Vicious cycle of hypertriglyceridaemia and hyperglycaemia in an atypical case of lipoprotein lipase deficiency. Tong HF; Kwan MT; Chan KW; Chong YK Pathology; 2022 Jun; 54(4):503-505. PubMed ID: 34635320 [No Abstract] [Full Text] [Related]
19. Update on the molecular biology of dyslipidemias. Ramasamy I Clin Chim Acta; 2016 Feb; 454():143-85. PubMed ID: 26546829 [TBL] [Abstract][Full Text] [Related]
20. Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient. Watts GF; Karpe F Heart; 2011 Mar; 97(5):350-6. PubMed ID: 21296781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]